Dr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respiratory tract disease in newborns caused by RSV. Dr. Reddy's will exclusively promote and distribute Beyfortus in India, with a launch expected in the second quarter of the current fiscal year, following regulatory approval.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/I0JRV7S
via IFTTT
No comments:
Post a Comment